Navigation Links
Quest PharmaTech's Prostate Cancer Program Update

sily confirmed by fluorescence detection. PDT treatment of the prostate gland causes complete glandular tissue ablation within the intact capsule. Sexual and urological functions appear to be intact after the treatment with some acute voiding difficulties observed within the first few days.

Based on the exciting pre-clinical results, Quest will be compiling a pre-IND package, including chemical and manufacturing, toxicology, pharmacology and clinical protocol, and seek a pre-IND meeting with regulatory authorities as we progress this technology towards human clinical trials.

"We are very excited about the treatment results, and its potential as a first line therapy for prostate cancer. This warrants further testing of this new technology in a clinical setting," said Dr. Ron Moore, Professor of Surgery and Oncology, Faculty of Medicine, University of Alberta and Cross Cancer Institute.

SL052 for the treatment of prostate cancer is being developed in collaborations with Dr. Ron Moore and Dr. Jimmy Xiao of the Alberta Cancer Board, Dr. John Tulip at the Faculty of Engineering, University of Alberta and Dr. Dwayne Dickey, with support from the Alberta Ingenuity Fund and the National Research Council Canada, Industrial Research Assistance Program (NRC-IRAP).

The Company's lead photodynamic therapy product, SL017, is a topical formulation indicated for dermatology applications. The utility of SL017 has already been demonstrated for hair removal applications in a Phase I clinical trial. In Jan 2007, the Company initiated a fifty patient pivotal clinical trial for the same indications. In addition, SL017 is currently undergoing a Canadian Phase I clinical trial for Actinic Keratosis.

About Quest PharmaTech Inc.

The Corporation is a publicly traded , Alberta-based drug development company committed to the development and commercialization of new pharmaceutical products. It is developing a series of products for the treatment of cance
'"/>




Page: 1 2 3

Related medicine technology :

1. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. To Stent or Not: Is That the Question?
4. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
7. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
10. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Quest PharmaTech Prostate Cancer Program Update
(Date:8/3/2015)... MINNEAPOLIS , Aug. 3, 2015 ... become a significant shareholder and will become the ... Solutions for cardiology-related diagnostic and monitoring offerings. ... milestone for Preventice Solutions," said Jon Otterstatter ... CEO, Preventice Solutions.  "We are thrilled to partner ...
(Date:8/3/2015)... (Nasdaq: DRRX ) announced today financial results for the ... net loss was $5.5 million for the three months ended ... million and net loss of $5.5 million for the three ... cash and investments of $37.8 million, compared to cash and ... 30, 2015, we had $19.8 million in long term debt. ...
(Date:8/3/2015)... -- Your doctor has recommended surgery for your foot ... possible outcome. Your orthopaedic foot and ankle specialist is ... a three-part online series to help you ... Orthopaedic Foot & Ankle Society (AOFAS) both before ... heal as quickly as possible. For example, ...
Breaking Medicine Technology:Boston Scientific Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10Patient Guide: How to Prepare for Surgery 2
... proliferation of brand drug "copay coupon" promotions, which lure ... increase costs by $1.4 billion in Illinois over the ... according to new research from Visante and released by ... use of these promotions by state and local government ...
... proliferation of brand drug "copay coupon" promotions, which lure ... increase costs by $2.1 billion in Florida over the ... according to new research from Visante and released by ... use of these promotions by state and local government ...
Cached Medicine Technology:Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $1.4 Billion in Illinois 2Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $2.1 Billion in Florida 2
(Date:8/3/2015)... ... August 03, 2015 , ... Representatives with Health Food Grocers today ... “Our ‘Ask a Nutritionist’ feature on our website is a free service to our ... nutritionist and spokeswoman for Health Food Grocers. , Health Food Grocers’ website offers a ...
(Date:8/3/2015)... ... ... The Workgroup for Electronic Data Interchange ( WEDI ), the nation’s leading ... exchange, announced the release of its findings from its June 2015 ICD-10 Industry Readiness ... survey results and recommendations , strongly encouraging the department to continue ...
(Date:8/3/2015)... ... August 03, 2015 , ... They know every second counts. And when ... Center offers some of the best care in the nation. For the past two ... fastest average blood clot removal time in the country. During the months of June ...
(Date:8/3/2015)... Princeton, NJ (PRWEB) , ... August 03, 2015 ... ... named a finalist in 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs ... by and for B2B brands. BESLER Consulting's campaign for the launch of their ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Seattle-based Genelex to offer pharmacogenetic lab testing and precision medicine solutions that can ... costs. , Annually, more than 8.6 million adverse drug events are reported ...
Breaking Medicine News(10 mins):Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 2Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 3Health News:WEDI ICD-10 Survey Results: Industry Nearing Readiness but Physician Practices Lagging Behind 4Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3
... adult rats by researchers provides evidence that explains exactly how ... ,The study shows that exposure to levels of ... reduce the birth and survival of new neurons (neurogenesis) in ... born neurons in a part of the brain (hippocampus) known ...
... to an American study, helping teenagers manage the stress involved ... safe sex//. , The study conducted by lead author ... the Warren Alpert Medical School of Brown University in Providence, ... 13 to 18. ,Lescano found that lack ...
... A private institution in the US has pledged to spend ... to combat childhood obesity// . ,The announcement by ... of the largest public health initiatives ever tried by private ... going to cost the country in terms of morbidity and ...
... United States, are now spreading their wings with distant shores ... Hopkins clinic will be set up at Tokyo, Japan. ... Japan’s growing discontent with the national health-care system. Accordingly, around ... by caring for an aging population. This has even got ...
... can increase your chance of developing a sleep disorder, ... the need for improved// diagnosis and treatment of sleep ... of insomnia. ,“As many as 40 to ... complain of insomnia,” said study author Liat Ayalon, PhD, ...
... hepatitis B virus (HBV) transmission between two patients at a ... infection is exceedingly rare, universal vaccination against the virus would ... ,The case report, by John T. Redd, ... and Prevention (CDC) and the New Mexico Department of Health, ...
Cached Medicine News:Health News:Research Explains How Lead Exposure Produces Learning Deficits 2Health News:500 Million US Dollars to Fight Childhood Obesity 2Health News:John Hopkins Hospitals- Now at Tokyo 2Health News:Mild Head Injuries Increase Risk of Sleep Disorders 2Health News:Rare Case of Hepatitis B Virus Transmission Between Dental Patients Recorded 2Health News:Rare Case of Hepatitis B Virus Transmission Between Dental Patients Recorded 3
... contains primers and a FAM-labeled probe that ... (RSV). In addition, this ASR contains primers ... sample processing control. This ASR requires an ... Red reporter dyes such as the Cepheid ...
... primers and a FAM-labeled probe that is designed ... Staphylococcus protein A gene. In addition, this ASR ... for an internal control sequence. This ASR requires ... Red reporter dyes such as the Cepheid SmartCycler ...
Clot-based Assay for Anti-FXa and/or Anti-Iia Therapies...
Reptilase-Time from Bothrops atrox...
Medicine Products: